Ki-Young Lee

Prof. Dr. Ki-Young Lee


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
KLKi-Young Lee
Ki-Young Lee
MIMitsuhiko Ikura
Mitsuhiko Ikura
CMChristopher Marshall
Christopher Marshall

20 February 2024 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
SLSoo‐Yeon Lee
Soo‐Yeon Lee
KLKi-Young Lee
Ki-Young Lee

13 August 2024 in Advanced Science
Verified
Journal Article
Open access
SLSoo‐Yeon Lee
Soo‐Yeon Lee
HEHyun‐Jong Eun
Hyun‐Jong Eun
KLKi-Young Lee
Ki-Young Lee
RAS proteins are peripheral membrane GTPases that activate multiple downstream effectors for cell proliferation and differentiation. The formation of a signaling RAS–RAF complex at the plasma membrane is implicated in a quarter of all human cancers; however, the underlying mechanism remains unclear. In this work, nanodisc platforms and paramagnetic relaxation enhancement (PRE) analyses to determine the structure of a hetero‐tetrameric complex comprising KRAS and the RAS‐binding domain (RBD) and cysteine‐rich domain (CRD) of activated RAF1 are employed. The binding of the RBD or RBD–CRD differentially alters the dimerization modes of KRAS on both anionic and neutral membranes, validated by interface‐specific mutagenesis. Notably, the RBD binding allosterically generated two distinct KRAS dimer interfaces in equilibrium, favored by KRAS free and in complex with the RBD–CRD, respectively. Additional interactions of the CRD with both KRAS protomers are mutually cooperative to stabilize a new dimer configuration of KRAS bound to the RBD–CRD. The RAF binding sequentially alters KRAS dimerization, providing new insights into RAF activation, including a configurational transition of the KRAS dimer to provide an interaction site for the CRD and release the autoinhibited RAF complex. These methods are applicable to many other signaling protein complexes on the membrane.

Verified
Journal Article
Open access
PDF file
KLKi-Young Lee
Ki-Young Lee
Transient homo-dimerization of the RAS GTPase at the plasma membrane has been shown to promote the mitogen-activated protein kinase (MAPK) signaling pathway essential for cell proliferation and oncogenesis. To date, numerous crystallographic studies have focused on the well-defined GTPase domains of RAS isoforms, which lack the disordered C-terminal membrane anchor, thus providing limited structural insight into membrane-bound RAS molecules. Recently, lipid-bilayer nanodisc platforms and paramagnetic relaxation enhancement (PRE) analyses have revealed several distinct structures of the membrane-anchored homodimers of KRAS, an isoform that is most frequently mutated in human cancers. The KRAS dimerization interface is highly plastic and altered by biologically relevant conditions, including oncogenic mutations, the nucleotide states of the protein, and the lipid composition. Notably, PRE-derived structures of KRAS homodimers on the membrane substantially differ in terms of the relative orientation of the protomers at an “α–α” dimer interface comprising two α4–α5 regions. This interface plasticity along with the altered orientations of KRAS on the membrane impact the accessibility of KRAS to downstream effectors and regulatory proteins. Further, nanodisc platforms used to drive KRAS dimerization can be used to screen potential anticancer drugs that target membrane-bound RAS dimers and probe their structural mechanism of action.

5 June 2026 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
JYJuwon Yoon
Juwon Yoon
SLSang-Hyeok Lee
Sang-Hyeok Lee
SMSoohan Moon
Soohan Moon
HGHarerta Gebremedhn
Harerta Gebremedhn
TGTeklab Gebregiworgis
Teklab Gebregiworgis
KLKi-Young Lee
Ki-Young Lee
The epidermal growth factor receptor (EGFR) is one of the most extensively studied targets in cancer therapy, yet its complex regulatory mechanisms remain partially understood. While traditional structural approaches have provided invaluable insights, the static crystal structures of individual domains have been limited to capturing the full dynamic nature of EGFR regulation. Understanding the complete structure of full-length EGFR has been challenging due to the inherent flexibility and complexity of the multidomain membrane protein. Here we integrate recent structural studies using cryo-electron microscopy, molecular dynamics simulations and single-molecule biophysics. Integrated knowledge has revealed that EGFR samples multiple transient conformational states of monomer and higher-order oligomers, and that activation requires coordinated structural transitions between the extracellular domain, transmembrane helix, juxtamembrane region and asymmetric kinase dimer. The allosteric coupling and oligomerization propensity of EGFR are altered by oncogenic mutations, membrane environments and ligand binding. Strategies that incorporate conformational dynamics, allosteric regulation and static structures of EGFR may yield inhibitors with improved selectivity and reduced resistance.

27 March 2023 in Angewandte Chemie
Verified
Journal Article
Closed access
KLKi-Young Lee
Ki-Young Lee
MIMitsuhiko Ikura
Mitsuhiko Ikura
CMChristopher B. Marshall
Christopher B. Marshall